Upgrade to SI Premium - Free Trial

Core Scientific reports Q3 revenue decline amid pending CoreWeave merger

October 24, 2025 4:05 PM

Core Scientific Inc. (NASDAQ: CORZ) reported third-quarter revenue of $81.1 million, down from $95.4 million in the same period last year, according to a press release from the digital infrastructure and bitcoin mining company.

The Austin-based company posted a net loss of $146.7 million for the quarter, compared to a net loss of $455.3 million in the prior-year period. The improvement was primarily due to a smaller non-cash fair value adjustment of $74.9 million related to outstanding warrants and contingent value rights, versus $408.5 million in the third quarter of 2024.

Digital asset self-mining revenue fell to $57.4 million from $68.1 million year-over-year, driven by a 55% decrease in bitcoin mined, though this was partially offset by an 88% increase in average bitcoin price. Digital asset hosted mining revenue dropped to $8.7 million from $16.9 million as the company continues its strategic shift toward high-density colocation services.

High-density colocation revenue increased to $15.0 million from $10.3 million in the third quarter of 2024, reflecting the expansion of colocation operations. The company reported gross profit of $3.9 million compared to a gross loss of $0.2 million in the prior year.

Core Scientific spent $244.5 million on capital expenditures during the quarter, with $196.4 million funded by CoreWeave Inc. under existing colocation service agreements. The company's liquidity totaled $694.8 million, consisting of $453.4 million in cash and cash equivalents and $241.4 million in bitcoin holdings.

The company is proceeding with a planned merger with CoreWeave, announced in July 2025. Under the all-stock transaction, Core Scientific shareholders would receive 0.1235 shares of CoreWeave Class A common stock for each Core Scientific share. The transaction requires approval from Core Scientific stockholders at a special meeting scheduled for October 30, 2025.

Due to the pending transaction, Core Scientific did not host an earnings conference call for the third quarter results.

Categories

Corporate News Mergers and Acquisitions

Next Articles